Constantine Chinoporos, the Chief Operating Officer and Chief Business Officer of Applied Therapeutics, Inc. (NASDAQ:APLT), a clinical-stage biopharmaceutical company with a market capitalization of ...

Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) by 13.6% during the 4th quarter, according to the company in its most ...

If PH-ILD studies translate into the real world, the market opportunity for Liquidia is enormous. Where should we expect LQDA stock to be in the next few months? Find out.

We recently compiled a list of the 10 Best Rebound Stocks To Invest In Now. In this article, we are going to take a look at ...

Over the last 7 days, the United States market has remained flat, yet it is up 22% over the past year with earnings expected to grow by 15% per annum in the coming years. In this context of steady ...

Viking Therapeutics stock plunged late Wednesday on an earnings report that included mostly incremental updates for its ...

Learn more about whether Biogen Inc. or Gilead Sciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Arquitos returned 29.6% net of fees and expenses in 2024, compared to 25.0% for the S&P 500. Click here to read the full ...

Shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Get Free Report) have been given a consensus recommendation of “Moderate ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...